Ευρωπαϊκή Ένωση - Λιθουανικά - EMA (European Medicines Agency)

marinus pharmaceuticals emerald limited - ganaxolone - epileptic syndromes; spasms, infantile - kiti antiepileptics - ztalmy is indicated for the adjunctive treatment of epileptic seizures associated with cyclin-dependent kinase-like 5 (cdkl5) deficiency disorder (cdd) in patients 2 to 17 years of age. ztalmy may be continued in patients 18 years of age and older.

Λιθουανία - Λιθουανικά - SMCA (Valstybinė vaistų kontrolės tarnyba)

niromed, uab - lamotriginas - kramtomosios ar disperguojamosios tabletės - 5 mg - lamotrigine

Λιθουανία - Λιθουανικά - SMCA (Valstybinė vaistų kontrolės tarnyba)

niromed, uab - lamotriginas - kramtomosios ar disperguojamosios tabletės - 25 mg - lamotrigine

Λιθουανία - Λιθουανικά - SMCA (Valstybinė vaistų kontrolės tarnyba)

niromed, uab - lamotriginas - kramtomosios ar disperguojamosios tabletės - 100 mg - lamotrigine

Λιθουανία - Λιθουανικά - SMCA (Valstybinė vaistų kontrolės tarnyba)

rivopharm ltd. - karbamazepinas - tabletės - 200 mg - carbamazepine

Λιθουανία - Λιθουανικά - SMCA (Valstybinė vaistų kontrolės tarnyba)

ebewe pharma ges.m.b.h. nfg. kg - metotreksatas - injekcinis ar infuzinis tirpalas - 2,5 mg; 100 mg/ml; 10 mg/ml - methotrexate

Λιθουανία - Λιθουανικά - SMCA (Valstybinė vaistų kontrolės tarnyba)

teva pharma b.v. - karbamazepinas - tabletės - 200 mg; 400 mg - carbamazepine

Ευρωπαϊκή Ένωση - Λιθουανικά - EMA (European Medicines Agency)

kite pharma eu b.v. - axicabtagene ciloleucel - lymphoma, follicular; lymphoma, large b-cell, diffuse - antinavikiniai vaistai - yescarta is indicated for the treatment of adult patients with diffuse large b cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl) that relapses within 12 months from completion of, or is refractory to, first-line chemoimmunotherapy. yescarta is indicated for the treatment of adult patients with relapsed or refractory (r/r) dlbcl and primary mediastinal large b cell lymphoma (pmbcl), after two or more lines of systemic therapy. yescarta is indicated for the treatment of adult patients with r/r follicular lymphoma (fl) after three or more lines of systemic therapy.

Λιθουανία - Λιθουανικά - SMCA (Valstybinė vaistų kontrolės tarnyba)

lex ano, uab - metotreksatas - tabletės - 5 mg - methotrexate

Ευρωπαϊκή Ένωση - Λιθουανικά - EMA (European Medicines Agency)

kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - limfoma, mantle-cell - antinavikiniai vaistai - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).